Trademark: 90673637
Word
GENE THERAPY READY
Status
Registered
Status Code
700
Status Date
Tuesday, December 20, 2022
Serial Number
90673637
Registration Number
6927368
Registration Date
Tuesday, December 20, 2022
Mark Type
4000
Filing Date
Tuesday, April 27, 2021
Published for Opposition
Tuesday, October 4, 2022

Trademark Owner History
Advarra, Inc. - Original Registrant

Classifications
35 organizing and administering a network of research sites, namely, business management in the field of clinical trials, specifically, providing governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes
45 Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects
42 Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, evaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, testing, analysis, and evaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards
"GENE THERAPY"

Trademark Events
Jan 25, 2023
Assignment Of Ownership Not Updated Automatically
Dec 20, 2022
Notice Of Registration Confirmation Emailed
Dec 20, 2022
Registered-Principal Register
Nov 2, 2022
Assignment Of Ownership Not Updated Automatically
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 29, 2022
Approved For Pub - Principal Register
Aug 29, 2022
Examiner's Amendment Entered
Aug 29, 2022
Notification Of Examiners Amendment E-Mailed
Aug 29, 2022
Examiners Amendment E-Mailed
Aug 29, 2022
Examiners Amendment -Written
Jul 29, 2022
Teas/Email Correspondence Entered
Jul 29, 2022
Correspondence Received In Law Office
Jul 29, 2022
Teas Response To Office Action Received
Feb 11, 2022
Notification Of Non-Final Action E-Mailed
Feb 11, 2022
Non-Final Action E-Mailed
Feb 11, 2022
Non-Final Action Written
Dec 23, 2021
Assigned To Examiner
Sep 24, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 24, 2021
Teas Change Of Correspondence Received
Sep 24, 2021
Teas Change Of Owner Address Received
Aug 2, 2021
New Application Office Supplied Data Entered
Apr 30, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24